53 related articles for article (PubMed ID: 17027833)
21. Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.
Masuo K
Int J Hypertens; 2010 Oct; 2010():832821. PubMed ID: 20981286
[TBL] [Abstract][Full Text] [Related]
22. The Gln27Glu polymorphism in β2-adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis.
Daghestani MH; Warsy A; Daghestani MH; Al-odaib AN; Eldali A; Al-Eisa NA; Al-zhrani S
Lipids Health Dis; 2010 Aug; 9():90. PubMed ID: 20738880
[TBL] [Abstract][Full Text] [Related]
23. Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women.
Kunnas T; Lahtio R; Kortelainen ML; Kalela A; Nikkari ST
Lipids Health Dis; 2009 Oct; 8():43. PubMed ID: 19832974
[TBL] [Abstract][Full Text] [Related]
24. Autism, asthma, inflammation, and the hygiene hypothesis.
Becker KG
Med Hypotheses; 2007; 69(4):731-40. PubMed ID: 17412520
[TBL] [Abstract][Full Text] [Related]
25. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
[TBL] [Abstract][Full Text] [Related]
26. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
[TBL] [Abstract][Full Text] [Related]
27. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.
Masuo K; Katsuya T; Sugimoto K; Kawaguchi H; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2007 Jun; 30(6):503-11. PubMed ID: 17664853
[TBL] [Abstract][Full Text] [Related]
28. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
29. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
[TBL] [Abstract][Full Text] [Related]
30. Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.
Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2006 Oct; 19(10):1084-91. PubMed ID: 17027833
[TBL] [Abstract][Full Text] [Related]
31. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes.
Leineweber K; Brodde OE
Life Sci; 2004 Apr; 74(23):2803-14. PubMed ID: 15072081
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
[TBL] [Abstract][Full Text] [Related]
33. beta2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese.
Ge D; Huang J; He J; Li B; Duan X; Chen R; Gu D
Ann Hum Genet; 2005 Jan; 69(Pt 1):36-44. PubMed ID: 15638826
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
